Higher intake of β-glucan impairs reproduction in a female teleost, Tor putitora (Hamilton, 1822)

Although the immuno-modulatory and stress-relieving properties of β-glucan is well elucidated in humans and other animal models, including fish, its role as a dietary supplement on reproduction is extremely scarce. Therefore, in this study, adult female fish were fed one of four test diets having 0 (control), 0.5, 1, and 1.5% β-D-glucan for 130 days and its effect on reproductive performance, ovarian and liver histology, sex hormones, and transcript abundance of selected reproduction-related genes was assessed. Low dietary intake of β-glucan improved fertilization and hatching rates (p<0.05). The relative fecundity and percentage of spawning females were higher (non-significant) in 0.5% β-glucan-fed groups. Surprisingly, even after 130 days, spawning did not occur in 1.5% β-glucan-fed individuals. Irrespective of β-glucan intake, all the brooders recorded similar plasma 17β-estradiol and maturation-inducing hormone (p>0.05). Higher intake of β-glucan (1.5%) upregulated aromatase genes without a parallel increase in 17β-estradiol. However, plasma vitellogenin increased with increasing β-glucan up to 1.0% then declined at 1.5% (p<0.05). The fish that received control, 0.5, and 1.5% β-glucan recorded similar vitellogenin levels in their plasma. Significantly higher plasma cortisol was evidenced in 1.5% β-glucan fed brooders (p<0.05). Histologically, higher follicular atresia and leaking of yolk material was evidenced in 1.5% β-glucan-fed group. Liver histology revealed the highest nutrient/lipid accumulation in fish that received 1.0% and 1.5% β-glucan. This study demonstrated the stimulatory effect of β-glucan intake at a lower dose (0.5%) on reproduction. However, higher intake (1.5%) could perturb normal reproductive function in a fish model and caused an increased number of atretic follicles leading to spawning/reproductive failure.

Effect of Saccharomyces cerevisiae supplementation during the suckling period on performance of Awassi ewes

This study aimed to investigate the impact of supplementing two levels of Saccharomyces cerevisiae (SC) during suckling period on performance and serum metabolites of Awassi ewes. The study comprised two experimental periods, for experimental period 1, 30 nursing Awassi ewes with their single lambs were randomly assigned to one of three equal treatment groups: a control diet (CON; n=10), low SC (LSC) diet (0.4 g SC/head/day; n=10), and high SC (HSC) diet (0.8 g SC/head/day; n=10) with 9-week experimental periods including 1 week for dietary and pen adaptation and 8 weeks for data and sample collection. For experimental period 2, 4 ewes from each group were randomly selected and were individually housed in metabolism crates with 7-day experimental periods including 3 days for crate adaptation and 4 days for data and sample collection. The results showed that the supplementation of SC improved dry matter (DM) intake of ewes (P = 0.03). Digestibility of DM was higher (P < 0.05) for SC treatment groups. The SC treatment groups had a tendency improvement in digestibility of crude protein, neutral detergent fiber, and acid detergent fiber. Addition of SC improved (P < 0.05) N balance parameters of ewes. A significant increase was observed for the rumen fluid pH of lactating ewe supplemented with SC. No difference was detected in the live weight change of lactating ewes in all treatment groups. The final body weight of the lambs tended to be greater for SC treatment groups vs CON group but average daily gain and total weight gain were significantly higher (P = 0.05) for SC treatment groups. Lactating ewes in the SC treatment groups produced more milk per day (P ≤ 0.05) than those in the CON diet. Milk fat % and yield in the SC treatment groups were also greater (P = 0.05). No differences were found in % of milk protein, lactose, and solid-not-fat (SNF) between all groups (P > 0.05) while lactose and SNF yields were greater (P < 0.05) for SC treatment groups. However, % of the total solids (TS) of milk was higher for HSC diet compared to LSC and CON diets (P < 0.05) while TS yields were significantly higher for SC treatment groups. Energy-corrected milk values were greater (P < 0.05) in HSC diet compared to LSC and CON diets. With the exception of aspartate aminotransferase and alkaline phosphatase, no differences were detected in all other serum metabolite concentrations of lactating ewes in between treatment groups. In conclusion, this study indicates that SC supplementation with varying levels in the diet had a similar positive effect on some performance and physiological parameters of lactating Awassi ewes and their lambs.

Saccharomyces cerevisiae Yeast-Based Supplementation as a Galactagogue in Breastfeeding Women? A Review of Evidence from Animal and Human Studies

Perceived insufficient milk production (PIM) adversely affects breastfeeding duration. Women sometimes use galactagogues with the intent to increase breast milk production and support lactation. Saccharomyces cerevisiae yeast-based supplement (SCYS) is an inactive form of Saccharomyces cerevisiae yeast (SCY) either obtained from the fermentation process or grown on molasses. Anecdotal evidence suggests SCYS is a galactagogue. SCYS is promoted on the internet as a galactagogue in various forms and doses. Dietary supplementation with SCYS during gestation and lactation significantly increases milk yield in ruminants. No human study has evaluated efficacy of SCYS as a galactagogue. SCYS is rich in B vitamins, beta-glucan, mannan oligosaccharides and bioavailable chromium; these may impact breast milk production or composition, thus may alleviate PIM. The safety of taking SCYS during lactation is not well studied. Studies have reported contamination of SCYS with ochratoxin A (OTA) as well as minor side effects from SCYS. Studies are needed to evaluate the efficacy of SCYS on breast milk production and composition and to assess the safety of taking SCYS during lactation in humans.

Innate Immunomodulation in Food Animals: Evidence for Trained Immunity?

Antimicrobial resistance (AMR) is a significant problem in health care, animal health, and food safety. To limit AMR, there is a need for alternatives to antibiotics to enhance disease resistance and support judicious antibiotic usage in animals and humans. Immunomodulation is a promising strategy to enhance disease resistance without antibiotics in food animals. One rapidly evolving field of immunomodulation is innate memory in which innate immune cells undergo epigenetic changes of chromatin remodeling and metabolic reprogramming upon a priming event that results in either enhanced or suppressed responsiveness to secondary stimuli (training or tolerance, respectively). Exposure to live agents such as bacille Calmette-Guerin (BCG) or microbe-derived products such as LPS or yeast cell wall ß-glucans can reprogram or "train" the innate immune system. Over the last decade, significant advancements increased our understanding of innate training in humans and rodent models, and strategies are being developed to specifically target or regulate innate memory. In veterinary species, the concept of enhancing the innate immune system is not new; however, there are few available studies which have purposefully investigated innate training as it has been defined in human literature. The development of targeted approaches to engage innate training in food animals, with the practical goal of enhancing the capacity to limit disease without the use of antibiotics, is an area which deserves attention. In this review, we provide an overview of innate immunomodulation and memory, and the mechanisms which regulate this long-term functional reprogramming in other animals (e.g., humans, rodents). We focus on studies describing innate training, or similar phenomenon (often referred to as heterologous or non-specific protection), in cattle, sheep, goats, swine, poultry, and fish species; and discuss the potential benefits and shortcomings of engaging innate training for enhancing disease resistance.

Effect of diet supplementation with live yeast (Saccharomyces cerevisiae) on performance of rabbit does and their progenies

<p>A study was conducted to determine the effect of live yeast supplementation in the diet of rabbit does on their mortality and reproductive performance and the performance of their progeny. A total of 52 cross-bred rabbit does (New Zealand×Californian) were divided into 2 groups differing in diet offered during 2 reproductive cycles and containing (group S; n=26) or not (group C; n=26) 1 g of yeast (Actisaf Sc 47, S.I. LESAFFRE, France)/kg of feed. Natural mating was performed 11 d after kindling and kits were weaned at 28 d of age. Body weight of litters was measured at birth, 21 d and at 28 d of age (weaning). Mortality of kits and rabbit does was monitored daily, and fertility of rabbit does and viability rate of kits at birth were also determined. Weight and litter size at birth and at weaning, litter weight gain during lactation and length of gestation were similar between the 2 groups during the 2 cycles. The mortality of does during the experiment was higher in group C than in group S (27 vs. 4%; P&lt;0.05). Fertility rate of rabbits does and viability rate of kits at birth were higher (P&lt;0.05) in rabbits fed with the supplemented diet than those with the control diet during the second lactation. In the first cycle, kit mortality was lower in S group (15.5%) than the C group (24.7%) during the first 21 d (P&lt;0.05). However, no difference was observed during the second lactation. In conclusion, our results suggest that the inclusion of yeast in the diet of rabbit does could trigger positive effects on the fertility and mortality of rabbit does, as well as on the viability rate of kits at birth.</p>